Fujifilm Sonosite Unveils Next-Gen Point-of-Care Ultrasound System for Frontline Clinicians

Fujifilm Sonosite Unveils Next-Gen Point-of-Care Ultrasound System for Frontline Clinicians

What You Should Know:

– FUJIFILM Sonosite, Inc. launches its next-generation point-of-care (POCUS) ultrasound system – designed specifically for the clinicians on the front lines of medicine to treat patients more effectively. 

– The
product is expected to commercialize in the US, Australia and New Zealand in
July 2020, and in the UK, Spain, Germany and France this August. Sonosite has
received nearly 600 leads (and counting) from healthcare providers and medical
facilities in the U.S. [and ANZ].


FUJIFILM Sonosite, Inc., specialists in
developing cutting-edge point-of-care
ultrasound (POCUS) solutions
, and part of the larger Fujifilm Healthcare
portfolio, has announced the launch of the new Sonosite PX ultrasound system.
Sonosite PX is the next generation in Sonosite POCUS, with the most advanced
image clarity ever seen in a Sonosite system, a suite of workflow efficiency
features, and an adaptable form factor. 

Designed Specifically for Front-Line Clinicians

Fujifilm Sonosite Unveils Next-Gen Point-of-Care Ultrasound System for Frontline Clinicians

The ultrasound system and the new family of transducers are drop-tested to one meter and the work surface is sealed to the edge for simplified cleaning and disinfection.  When mounted on the specialized stand, Sonosite PX has an adaptable worksurface position for optimal clinician ergonomics while a small footprint and adjustable height allow for closer bedside access. Information essential to completing an exam including patient information, reports, and worksheets, is intuitively placed in one location, saving clinicians time and effort when navigating the ultrasound system user interface.

Recognizing the importance of efficient documentation to the
electronic health record
(EHR),
Sonosite PX has been designed for onboard documentation of ultrasound
findings at the bedside. Sonosite PX integrates seamlessly with the
company’s Sonosite Synchronicity solution, a workflow manager for
POCUS that supports seamless credentialing, quality assurance, and billing
across departments and institutions.

An overview of the system’s competitive features
include: 

Exceptional Imaging Clarity – as a result of advanced
speckle reduction technology. Seeing anatomy more clearly provides clinicians
with an unparalleled level of confidence for diagnostic and procedural
applications.

Suite of Workflow Efficiency Features – the
streamlined user interface improves workflow, allowing even novice clinicians
to find controls quickly with fewer touches.

Adaptable Form Factor – designed to optimize
clinician ergonomics and improve efficiency, the system has an adaptable work
surface that can be used in a horizontal or vertical position based on the
situational needs of the exam.

Why It Matters

Today, POCUS is quickly emerging as a reliable and critical tool to diagnose, monitor, and manage patients in emergency departments and those admitted to inpatient services. Sonosite’s newest bleeding-edge system presents a new world where POCUS is no longer looked at as a device- but rather a partner for clinicians.

“Every aspect of Sonosite PX was designed specifically for the clinicians on the front lines of medicine. We designed Sonosite PX as a tool to help clinicians in all fields of medicine to treat patients more effectively where it matters most – at the point of care.” said Rich Fabian, President and Chief Operating Officer of FUJIFILM Sonosite, Inc. “To optimize clinician ergonomics and improve efficiency, the system has an innovative and adaptable work surface that can be used in a horizontal or vertical position based on the situational needs of the exam. The exceptional image clarity is the result of a new proprietary imaging technology – seeing anatomy more clearly with Sonosite PX provides an unparalleled level of confidence for diagnostic and procedural applications.”

Commercial Roll-Out Plans

The product is expected to commercialize in the US,
Australia and New Zealand in July 2020, and in the UK, Spain, Germany and
France this August. Sonosite has received nearly 600 leads (and counting) from
healthcare providers and medical facilities in the U.S. [and ANZ].